Disturbances of acquired immunity in hemodialysis patients. - Wikidata - awgldk - TriplyDB

Disturbances of acquired immunity in hemodialysis patients.

Disturbances of acquired immunity in hemodialysis patients.

http://www.wikidata.org/entity/Q33344667

about

Cytochrome c as a Potentially Clinical Useful Marker of Mitochondrial and Cellular Damage Immune dysfunction in uremia—an update Influenza and the patient with end-stage renal disease.Immune response after a single vaccination against 2009 influenza A H1N1 in hemodialysis patients.Antibody response after single H1N1 influenza vaccine in chronic dialysis patients.Potential role of the soluble form of CD40 in deficient immunological function of dialysis patients: new findings of its amelioration using polymethylmethacrylate (PMMA) membrane.Potential Hepatoprotective Role of Galectin-3 during HCV Infection in End-Stage Renal Disease Patients.Biology of sepsis: its relevance to pediatric nephrology.Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD.High prevalence of latent tuberculosis infection in dialysis patients using the interferon-gamma release assay and tuberculin skin test.Evidence for anti-inflammatory effects of exercise in CKD.Effects of parathyroid hormone on immune function.Factors affecting effectiveness of vaccination against hepatitis B virus in hemodialysis patients Association of response to hepatitis B vaccination and survival in dialysis patients Impact of seropositivity to Chlamydia pneumoniae and anti-hHSP60 on cardiovascular events in hemodialysis patients A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients Protein-energy wasting and mortality in chronic kidney disease.Hepatitis C in hemodialysis patients Alterations of intestinal barrier and microbiota in chronic kidney disease.Infections in hemodialysis: a concise review. Part II: blood transmitted viral infections Controlling Time-Dependent Confounding by Health Status and Frailty: Restriction Versus Statistical Adjustment.Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study.The risk of hospitalization and modality failure with home dialysis.Th2-biased GATA-3 transgenic mice developed severe experimental peritoneal fibrosis compared with Th1-biased T-bet and Th17-biased RORγt transgenic mice.Prognostic impact of peritonitis in hemodialysis patients: A national-wide longitudinal study in Taiwan.Chronic kidney disease worsens sepsis and sepsis-induced acute kidney injury by releasing High Mobility Group Box Protein-1 Comparative effectiveness of home dialysis therapies: a matched cohort study Serum phosphate levels and risk of infection in incident dialysis patients.Altered molecular repertoire of immune system by renal dysfunction in the elderly: is prediction and targeted prevention in the horizon?Comparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation.Epidemiology of acute infections among patients with chronic kidney disease Aspects of immune dysfunction in end-stage renal disease Obesity management in adults with CKD.Seropositivity for anti-HCV core antigen is independently associated with increased all-cause, cardiovascular, and liver disease-related mortality in hemodialysis patients.Vitamin D and the Immune System from the Nephrologist's Viewpoint.The Prevalence of Toxoplasma gondii in Hemodialysis Patients Serum vitamin D levels are positively associated with varicella zoster immunity in chronic dialysis patients.Preventing catheter-related infections in children undergoing hemodialysis.IFN-α as a vaccine adjuvant: recent insights into the mechanisms and perspectives for its clinical use.Infections in hemodialysis: a concise review - Part 1: bacteremia and respiratory infections.

P2860

Q26739555-7142DF2E-F8D8-4362-9CBF-43758110AA94 Q26829076-6C455AAD-CE9C-49F6-B654-916F19C21DA5 Q30252363-B39D9540-FE06-45B9-874E-439D9B8340E1 Q30390246-1EF4C93C-3291-4127-AB6C-7837AA5EB2C7 Q30426760-56835630-9A67-4F71-9AFC-A66CB905D457 Q33362890-0B922034-AB9A-4FB8-8363-3DD949F26890 Q33604689-A7495208-227E-480A-986E-433866E3B2F4 Q33882451-2B85BF55-3EBF-4F08-98D0-7A37B8D147E6 Q33999246-742F1F0E-E288-41D6-B7C0-D5A677CA1776 Q34075496-FDA290C2-B537-4043-A9A8-5CA99B5B5121 Q34103416-B7CF2F65-6DD6-424B-9787-B757461DA21D Q34155707-C348D6A6-B151-4F19-9634-77F13A9249AA Q34168451-1AC5B561-B778-43CF-8169-90C3A45CCB65 Q34398430-B2D58ED4-4326-4020-87EB-790019DE81DB Q34690945-4D842549-4656-44B0-9BF5-0FC2B95CC04F Q34714685-9DD6D313-D711-4DF7-A709-0F40A292CDC6 Q35024794-660652F7-AF9F-4A8D-BF4E-509AAD1E3A83 Q35237329-C7D694DD-39D4-4ADD-ADAA-9AE9955C001E Q35239148-21E7B4A4-572E-49F3-9C99-253560B4F6B9 Q35532440-FAB25B41-98E5-455A-A619-D4D8F5766B56 Q35775682-0FEA1996-55DB-42C4-B6B4-AF85444940FD Q35887127-E0B4F278-8655-46D4-9C5F-BB494E3F9127 Q35921858-65E5374C-A6CC-445D-A410-5FCC45A91AC3 Q36260811-426919D2-1291-4E6A-B90E-20AB7FED5D47 Q36310642-B4799A1E-C9F4-45BF-BA24-4CC11343A9F0 Q36379017-BB55B051-A1A2-47B0-AE67-A9B3FF1E6F54 Q36714506-DD507993-822F-4E7A-A055-8C353AD90146 Q36843401-C074091E-316E-4CFF-A5F1-8EF9E59C690F Q37056846-62C9B735-059A-497A-824F-7549CC8760B0 Q37065658-3BC151A1-3014-43BC-9DEF-F3987DEA0075 Q37225033-F4687B6A-3775-48D4-8C7C-BF187EBA5B4A Q37243143-F5EE43AE-A735-4EF0-9B6A-765CC2612A3C Q37356229-3DEB109D-FB01-426A-9D62-5462E925C40C Q37506465-1CCF04D8-B2F7-4162-ACAE-E2284F35DC28 Q37576846-0303B3BC-C642-49D2-BD43-672F52B2AF24 Q37631984-54BE74EE-42EE-4C3F-927A-FF3E139C8567 Q37734398-C108591B-BA06-4F05-BE6A-E9A87230B5CE Q37809056-38B04BB3-E195-47DE-8E3E-622D1DBE3FA1 Q37867104-ECEB794D-B6C3-40D8-9042-A0D688B78A02 Q37878862-60093469-8303-4DB1-BCD8-2C6A7B1ED30E

P2860

Disturbances of acquired immunity in hemodialysis patients.

http://www.wikidata.org/entity/Q33344667

description

2007 nî lūn-bûn

@nan

2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Disturbances of acquired immunity in hemodialysis patients.

@ast

Disturbances of acquired immunity in hemodialysis patients.

@en

type

label

Disturbances of acquired immunity in hemodialysis patients.

@ast

Disturbances of acquired immunity in hemodialysis patients.

@en

prefLabel

Disturbances of acquired immunity in hemodialysis patients.

@ast

Disturbances of acquired immunity in hemodialysis patients.

@en

P1433

Q33344667-911328F2-06B0-4D41-A409-ABD0D1E7D68C

P1476

Q33344667-FDB7C8EA-FA58-4CD4-87F4-E243E29FE8C6

P2093

Q33344667-0FF38E69-C8B8-4700-81EC-35EC901B6415

Q33344667-58B4A48C-8941-4C4B-B90B-9B1C76343CC8

Q33344667-90B82283-21D3-4FF1-9223-44CE63637470

Q33344667-A3DBFD5E-2299-497D-802D-70756403C538

P2860

Q33344667-3EE1D0D8-72ED-4046-85FF-7731A64D52CC

Q33344667-68BC69FB-9291-4E41-A29B-223AFFF78D34

Q33344667-97276988-9DDE-4E6C-9605-9C9AA3A82E5E

Q33344667-C8108B93-A89A-4AE4-86AC-DFB642F44871

Q33344667-FEB0C4EB-F4CD-4B16-8F93-77E5E40DD173

P304

Q33344667-A8FF9D33-A2AB-42DD-B397-F6A4D82F239D

P31

Q33344667-46719511-0207-461C-ACE7-1A6BC403BF11

P356

Q33344667-7726547D-E4A5-45D2-9459-74CF84E77350

P433

Q33344667-A2C6F1FC-800D-4AD6-85CA-694A95349DD7

P478

Q33344667-DDEFB9D2-C404-4989-B738-124756DBB673

P50

Q33344667-CA03AEC8-AA34-4BF6-A172-D5AB0EFEC23D

P577

Q33344667-7F475172-09EE-4B66-9155-A861F95B5283

P698

Q33344667-56DD7CE9-4853-49DB-A0A9-8A3432E74892

P356

J.1525-139X.2007.00283.X

P1433

Seminars in Dialysis

P1476

Disturbances of acquired immunity in hemodialysis patients.

@en

P2093

Charalambos Kartsios

http://www.w3.org/2001/XMLSchema#string

Georgia Antoniadi

http://www.w3.org/2001/XMLSchema#string

Ioannis Stefanidis

http://www.w3.org/2001/XMLSchema#string

Theodoros Eleftheriadis

http://www.w3.org/2001/XMLSchema#string

P2860

The malnutrition, inflammation, and atherosclerosis (MIA) syndrome -- the heart of the matter.

Regulation of the acute phase response by cytokines.

Recombinant erythropoietin reverses polymorphonuclear granulocyte dysfunction in iron-overloaded dialysis patients.

Dialysis and transplantation in patients with renal failure due to systemic lupus erythematosus. The Australian and New Zealand experience.

Correction of deficient phagocytosis during erythropoietin treatment in maintenance hemodialysis patients.

P304

440-451

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1525-139X.2007.00283.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Vassilios Liakopoulos

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17897251

http://www.w3.org/2001/XMLSchema#string